With drugs belonging to the glucagon-like peptide-1 (GLP-1) receptor agonist class gaining attention for weight management, specialists have cautioned that women with PMOS need an individualised treatment plan based on their symptoms, weight, metabolic health and reproductive goals.
News
Weight-loss injections are not PMOS cure; experts caution against self-medication
November 2, 2026With drugs belonging to the glucagon-like peptide-1 (GLP-1) receptor agonist class gaining attention for weight management, specialists have cautioned that women with PMOS need an individualised treatment plan based on their symptoms, weight, metabolic health and reproductive goals.